Veravas is a diagnostic company transforming the practice of laboratory medicine by leveraging a breakthrough sample prep technology.
Veravas delivers superior test results, providing confidence to clinicians and patients that diagnoses are accurate.
Veravas was founded in 2017 by John Forrest. The company is headquartered in Oakdale, Minnesota, with an office in Charleston, South Carolina.
Veravas’ proprietary sample preparation technology uses nanomagnetic beads that can be added to patient test samples. This core technology enables the simple, efficient and cost effective capture of specific substances for removal and to concentrate and quantify those factors for improved measurement of complex biomarkers.
Veravas is rapidly driving the commercialization of proprietary sample preparation products and new diagnostic tests. Veravas’ nanomagnetic particles can identify, remove, and measure select substances from patient samples to reduce the effects of complex interferences and detect low-abundance biomarkers.
Veravas has raised $4M in a Seed round on Feb 19, 2020. The investment was backed by private investors through the issuance of convertible notes.